All articles by GlobalData Healthcare

  1. Wanted: Large-scale vaccine manufacturer for coronavirus vaccine

    Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline. Moderna’s…
    Read More…

    14 Feb
  2. Coronavirus’s impact on Hubei’s pharma manufacturing activity is temporary, says local CEO

    Follow the latest updates of the outbreak on our timeline. The Chinese Government has authorized biotech companies in Wuhan, the epicentre of…
    Read More…

    13 Feb
  3. Regeneron’s therapeutic candidate for rare cholesterol disease expected to face pricing pressure

    As high drug prices continue to incite public outcry and US legislation, it is nonetheless possible that Regeneron Pharmaceuticals’ drug…
    Read More…

    13 Feb
  4. Zogenix’s fenfluramine uptake inertia expected in Dravet syndrome

    Zogenix’s Fintepla (fenfluramine) as an adjunctive therapy for Dravet syndrome faces rocky uptake prospects despite expert anticipation of a straightforward…
    Read More…

    12 Feb
  5. CDC identifies significant racial disparity among newly diagnosed cases of HIV

    The US Centers for Disease Control and Prevention (CDC) recently published nationwide data in the Morbidity and Mortality Weekly Report…
    Read More…

    12 Feb
  6. China coronavirus outbreak is advancing fast and furiously; what to expect next?

    The five key events we at GlobalData had identified to watch for during the novel coronavirus outbreak occurred in the…
    Read More…

    12 Feb
  7. Lynparza expands the armamentarium for tackling ovarian cancer in the UK

    The rising costs of medicines worldwide have resulted in many healthcare systems struggling to make these costly therapies available for…
    Read More…

    11 Feb
  8. Traditional big pharma deal strategies must be adapted to foster innovation

    Pharmaceutical innovation is changing, and so the big pharma business model must evolve too, especially in the deals space, urged…
    Read More…

    7 Feb
  9. GlaxoSmithKline steps in to speed up 2019-nCoV vaccine development

    The Coalition of Epidemic Preparedness Innovations (CEPI) is a public-private partnership that was set up to accelerate the development of…
    Read More…

    7 Feb
  10. Esperion’s cholesterol-lowering therapy will offer new option for statin-intolerant patients

    On January 31, Esperion Therapeutics announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines…
    Read More…

    7 Feb
Close
Close
Close

Go Top